Mark Kirkpatrick
Family Medicine · Louisville, KYNPI 1235182304
Payments from drug & device makers
Across 139 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$463
- Lilly USA, LLC$307
- AstraZeneca$217
- Boehringer Ingelheim$155
- Shield Therapeutics Inc$124
- Novartis$109
- plus $944 from 25 others
What the payments were for
- Travel & lodging$141%
- Food & beverage$2,30599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $463 |
| Lilly USA, LLC | 23 | $307 |
| AstraZeneca | 9 | $217 |
| Boehringer Ingelheim | 10 | $155 |
| Shield Therapeutics Inc | 1 | $124 |
| Novartis | 7 | $109 |
| GSK | 6 | $95 |
| Pfizer | 5 | $71 |
| Abbott | 4 | $70 |
| Johnson & Johnson | 5 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Merck | 3 | $57 |
| Novo Nordisk | 4 | $57 |
| Medtronic | 1 | $56 |
| Astellas Pharma US Inc | 3 | $52 |
| Melinta Therapeutics, LLC | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 3 | $38 |
| Sanofi-aventis U.S. LLC | 3 | $35 |
| Amgen | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 2 | $25 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,319 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 30 | $30,846 |
| EliquisApixaban | 35 | $29,468 |
| FarxigaDapagliflozin Propanediol | 30 | $22,093 |
| JardianceEmpagliflozin | 32 | $20,252 |
| JanuviaSitagliptin Phosphate | 31 | $18,333 |
| LinzessLinaclotide | 22 | $13,726 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $13,444 |
| XareltoRivaroxaban | 17 | $12,092 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $11,675 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $10,686 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $4,976 |
| BrilintaTicagrelor | 11 | $4,781 |
| Ventolin HfaAlbuterol Sulfate | 57 | $4,498 |
| MovantikNaloxegol Oxalate | 11 | $4,495 |
| Levemir FlexpenInsulin Detemir | 13 | $3,261 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $155 | $30,93946 claims |
| Novo NordiskOzempic | $57 | $30,84630 claims |
| PfizerEliquis | $71 | $29,46835 claims |
| AstraZenecaFarxiga, Brilinta | $217 | $26,87441 claims |
| MerckJanuvia | $57 | $18,33331 claims |
| AbbVieLinzess, Synthroid | $463 | $14,87147 claims |
| GSKTrelegy Ellipta | $95 | $13,44422 claims |
| Johnson & JohnsonXarelto | $63 | $12,09217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Louisville
- Christopher RhyneLouisville$1M
- Michael LovelaceLouisville$244K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- Rajanbhai AminLouisville$26K
- James WrightLouisville$18K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.